nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—EDNRB—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0478	0.066	CbGpPWpGaD
MACITENTAN—CYP2C19—urine—adrenal gland cancer	0.043	0.155	CbGeAlD
MACITENTAN—EDNRA—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0342	0.0473	CbGpPWpGaD
MACITENTAN—EDNRB—adrenal cortex—adrenal gland cancer	0.0323	0.117	CbGeAlD
MACITENTAN—EDNRA—GPCRs, Other—GNRHR—adrenal gland cancer	0.029	0.0401	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelin Pathways—GNAS—adrenal gland cancer	0.0283	0.0391	CbGpPWpGaD
MACITENTAN—EDNRB—cardiac atrium—adrenal gland cancer	0.0267	0.0966	CbGeAlD
MACITENTAN—EDNRA—adrenal cortex—adrenal gland cancer	0.0267	0.0965	CbGeAlD
MACITENTAN—EDNRB—pituitary gland—adrenal gland cancer	0.0261	0.0943	CbGeAlD
MACITENTAN—EDNRB—Peptide GPCRs—TSHR—adrenal gland cancer	0.0255	0.0353	CbGpPWpGaD
MACITENTAN—CYP3A4—urine—adrenal gland cancer	0.0254	0.0919	CbGeAlD
MACITENTAN—EDNRB—adrenal gland—adrenal gland cancer	0.0233	0.0843	CbGeAlD
MACITENTAN—EDNRB—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0227	0.0315	CbGpPWpGaD
MACITENTAN—EDNRA—cardiac atrium—adrenal gland cancer	0.0221	0.0798	CbGeAlD
MACITENTAN—EDNRA—EGFR-dependent Endothelin signaling events—EGFR—adrenal gland cancer	0.0218	0.0301	CbGpPWpGaD
MACITENTAN—EDNRA—pituitary gland—adrenal gland cancer	0.0216	0.078	CbGeAlD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0203	0.0281	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelin Pathways—GNAS—adrenal gland cancer	0.0203	0.028	CbGpPWpGaD
MACITENTAN—EDNRA—adrenal gland—adrenal gland cancer	0.0193	0.0697	CbGeAlD
MACITENTAN—EDNRA—Peptide GPCRs—TSHR—adrenal gland cancer	0.0183	0.0252	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelins—CDC42—adrenal gland cancer	0.0177	0.0244	CbGpPWpGaD
MACITENTAN—EDNRB—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.0164	0.0227	CbGpPWpGaD
MACITENTAN—EDNRA—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0163	0.0225	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0151	0.0208	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0146	0.0201	CbGpPWpGaD
MACITENTAN—EDNRB—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0136	0.0188	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelins—CDC42—adrenal gland cancer	0.0126	0.0175	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.0122	0.0169	CbGpPWpGaD
MACITENTAN—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.0117	0.0162	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0115	0.0159	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0108	0.0149	CbGpPWpGaD
MACITENTAN—ALB—adrenal gland—adrenal gland cancer	0.0102	0.0369	CbGeAlD
MACITENTAN—EDNRA—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00975	0.0135	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00903	0.0125	CbGpPWpGaD
MACITENTAN—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00876	0.0121	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00872	0.0121	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00821	0.0114	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00804	0.0111	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00687	0.0095	CbGpPWpGaD
MACITENTAN—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—adrenal gland cancer	0.00654	0.00904	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00648	0.00896	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00646	0.00893	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—TSHR—adrenal gland cancer	0.00613	0.00847	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00589	0.00814	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00576	0.00796	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00492	0.0068	CbGpPWpGaD
MACITENTAN—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00481	0.00665	CbGpPWpGaD
MACITENTAN—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00479	0.00663	CbGpPWpGaD
MACITENTAN—ALB—Lipid and lipoprotein metabolism—PRKACA—adrenal gland cancer	0.00471	0.00651	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.0047	0.00649	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00464	0.00642	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—TSHR—adrenal gland cancer	0.00438	0.00606	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00421	0.00583	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00388	0.00537	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—SPARC—adrenal gland cancer	0.00383	0.0053	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—adrenal gland cancer	0.00365	0.00505	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—GNAS—adrenal gland cancer	0.00356	0.00493	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00353	0.00488	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—GNRHR—adrenal gland cancer	0.00348	0.00481	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00346	0.00479	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00336	0.00465	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00323	0.00447	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00315	0.00436	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—TSHR—adrenal gland cancer	0.00314	0.00435	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00304	0.0042	CbGpPWpGaD
MACITENTAN—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00289	0.004	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00278	0.00384	CbGpPWpGaD
MACITENTAN—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00275	0.00381	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—IGF2—adrenal gland cancer	0.00264	0.00366	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—GNAS—adrenal gland cancer	0.00255	0.00353	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00252	0.00349	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—adrenal gland cancer	0.00252	0.00348	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—GNRHR—adrenal gland cancer	0.00249	0.00344	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00248	0.00343	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00241	0.00333	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—POMC—adrenal gland cancer	0.0024	0.00332	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00231	0.0032	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00226	0.00312	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00226	0.00312	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—TSHR—adrenal gland cancer	0.00225	0.00311	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00218	0.00301	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00211	0.00291	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—GNRH1—adrenal gland cancer	0.00208	0.00288	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00201	0.00278	CbGpPWpGaD
MACITENTAN—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00199	0.00276	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CDC42—adrenal gland cancer	0.00191	0.00265	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—SPRY2—adrenal gland cancer	0.00191	0.00263	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TSHR—adrenal gland cancer	0.00186	0.00257	CbGpPWpGaD
MACITENTAN—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00184	0.00255	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—GNAS—adrenal gland cancer	0.00183	0.00253	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MEN1—adrenal gland cancer	0.00175	0.00241	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00172	0.00238	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—POMC—adrenal gland cancer	0.00172	0.00237	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.0017	0.00235	CbGpPWpGaD
MACITENTAN—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00162	0.00224	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00161	0.00223	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00151	0.00209	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—GNRH1—adrenal gland cancer	0.00149	0.00206	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00144	0.00199	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CDC42—adrenal gland cancer	0.00137	0.00189	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SPRY2—adrenal gland cancer	0.00136	0.00189	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—POMC—adrenal gland cancer	0.00136	0.00187	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PRKACA—adrenal gland cancer	0.00133	0.00184	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TSHR—adrenal gland cancer	0.00133	0.00184	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—GNAS—adrenal gland cancer	0.00131	0.00181	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.0013	0.0018	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MEN1—adrenal gland cancer	0.00125	0.00173	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—POMC—adrenal gland cancer	0.00123	0.0017	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00122	0.00168	CbGpPWpGaD
MACITENTAN—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0012	0.00166	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.00117	0.00162	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CDC42—adrenal gland cancer	0.00113	0.00156	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IGF2—adrenal gland cancer	0.00109	0.00151	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—GNAS—adrenal gland cancer	0.00108	0.00149	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IGF1R—adrenal gland cancer	0.00105	0.00146	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TP53—adrenal gland cancer	0.000977	0.00135	CbGpPWpGaD
MACITENTAN—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000972	0.00134	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—POMC—adrenal gland cancer	0.00097	0.00134	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PRKACA—adrenal gland cancer	0.000954	0.00132	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000923	0.00128	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TERT—adrenal gland cancer	0.000907	0.00125	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—POMC—adrenal gland cancer	0.000881	0.00122	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—SPARC—adrenal gland cancer	0.000876	0.00121	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000859	0.00119	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SDHB—adrenal gland cancer	0.000856	0.00118	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000829	0.00115	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CDC42—adrenal gland cancer	0.000809	0.00112	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—BAD—adrenal gland cancer	0.000789	0.00109	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IGF2—adrenal gland cancer	0.00078	0.00108	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—GNAS—adrenal gland cancer	0.000773	0.00107	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.000768	0.00106	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IGF1R—adrenal gland cancer	0.000754	0.00104	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PRKACA—adrenal gland cancer	0.00074	0.00102	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—POMC—adrenal gland cancer	0.000727	0.00101	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—BRAF—adrenal gland cancer	0.000718	0.000993	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—EGFR—adrenal gland cancer	0.000696	0.000963	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000673	0.000931	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TERT—adrenal gland cancer	0.000649	0.000897	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00064	0.000885	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—CDC42—adrenal gland cancer	0.000627	0.000867	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IGF2—adrenal gland cancer	0.000605	0.000836	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000604	0.000836	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—GNAS—adrenal gland cancer	0.000599	0.000829	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—BAD—adrenal gland cancer	0.000565	0.000781	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SDHD—adrenal gland cancer	0.000551	0.000762	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—RRM1—adrenal gland cancer	0.000551	0.000762	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—POMC—adrenal gland cancer	0.000521	0.00072	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000519	0.000718	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000519	0.000717	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000517	0.000714	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—BRAF—adrenal gland cancer	0.000514	0.000711	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000509	0.000704	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—EGFR—adrenal gland cancer	0.000498	0.000689	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.000495	0.000684	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.000495	0.000684	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000462	0.000639	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—EGFR—adrenal gland cancer	0.000411	0.000569	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—MED12—adrenal gland cancer	0.000411	0.000568	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000372	0.000514	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000369	0.00051	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000367	0.000508	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TP53—adrenal gland cancer	0.000345	0.000477	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00033	0.000456	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PRKACA—adrenal gland cancer	0.0003	0.000415	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000298	0.000411	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000298	0.000411	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—EGFR—adrenal gland cancer	0.000294	0.000407	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000293	0.000405	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	0.000269	0.000372	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000263	0.000364	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TP53—adrenal gland cancer	0.000247	0.000342	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GNAS—adrenal gland cancer	0.000243	0.000336	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ABCB1—adrenal gland cancer	0.000238	0.00033	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000222	0.000307	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GNAS—adrenal gland cancer	0.000218	0.000302	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	0.000214	0.000296	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TP53—adrenal gland cancer	0.000192	0.000265	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—POMC—adrenal gland cancer	0.000164	0.000226	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000162	0.000224	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—POMC—adrenal gland cancer	0.000147	0.000203	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000131	0.000181	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTGS2—adrenal gland cancer	0.000131	0.00018	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000129	0.000178	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	0.000117	0.000162	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—POMC—adrenal gland cancer	8.83e-05	0.000122	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	7.05e-05	9.74e-05	CbGpPWpGaD
